Fucci System

The system links fluorescent proteins to selected fragments of Cdt1 and Geminin, rather than using the full regulatory proteins. These fragments remain detectable during particular cell-cycle states but are selectively removed when phase-specific ubiquitin ligases target them for ubiquitin-mediated proteolysis. Their changing abundance produces fluorescence transitions that correspond to progression through G1, S, G2, and M phases.

Ubiquitin-mediated proteolysis provides the timing mechanism that changes the indicator as cells progress through the cycle. Because different ubiquitin ligases act during different phases, the tagged Cdt1 and Geminin fragments are degraded in a regulated sequence. This phase-dependent removal prevents the signal from remaining static and allows researchers to follow cell-cycle transitions in living cells.

Sequential fluorescence changes reveal when individual cells move between G1, S, G2, and M phases. Observing these transitions over time provides information about dynamic behavior rather than only a single measurement of cell state. This makes it possible to examine differences among cells, including heterogeneous proliferation patterns that may be obscured when populations are assessed as a whole.

Researchers introduce the genetically encoded indicator into the living-cell model being studied, then monitor fluorescence as cells progress through the cycle. The approach can be applied to cultured cells, organoids, and animal models, allowing observations at the level of individual cells. The resulting time-resolved signals help connect cell-cycle state with growth, treatment response, or tissue behavior.

In tumor studies, Fucci fluorescence can identify how individual tumor cells move through cell-cycle phases and reveal variation in proliferation within the same model. Tracking these patterns over time helps researchers examine tumor growth as a dynamic and heterogeneous process. Measurements in cultures, organoids, or animal models can therefore add cellular detail to investigations of tumor behavior.

When a treatment alters proliferation, changes in the observed phase-associated fluorescence can indicate where cells accumulate or stop progressing. This provides a way to examine drug-induced cell-cycle arrest in living models rather than relying only on an endpoint. Researchers can use the measurements to compare treatment responses among individual cells and identify heterogeneous responses within a population.

The system also supports studies of tissue regeneration and development, where cell-cycle timing can change as cells grow, replace damaged tissue, or undergo developmental transitions. Applying Fucci in organoids and animal models allows researchers to follow these processes in context. Such observations can clarify how proliferation dynamics differ across cells during regeneration or developmental progression.